We observed the induction of inflammatory signals in the CRC PDOs, including upregulation of IL-6, CXCL6, IL-1B, and TNFAIP6 expression, in response to both treatments (online supplemental figure S7D). This evidence concerns the gene IL1B and colorectal carcinoma.